Related Experiment Video

Updated: Jul 18, 2026

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
11:12

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on: August 1, 2018

MNK1 and MNK2 regulation in HER2-overexpressing breast cancer lines

Carol A Chrestensen1, Jacquelyn K Shuman1, Andrew Eschenroeder1

  • 1Department of Pharmacology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908.

The Journal of Biological Chemistry
|November 30, 2006
PubMed

Insights

MAPK-interacting protein kinases (MNKs) are activated in HER2-overexpressing breast cancers. Inhibiting MNK activity reduced cancer cell growth, identifying MNKs as potential therapeutic targets.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • MAPK-interacting protein kinases 1 and 2 (MNK1 and MNK2) are downstream effectors of p38 and ERK MAPK pathways.
  • MNKs are activated in the HER2/Ras/Raf/ERK signaling cascade, implicating them in HER2-overexpressing cancers.

Purpose of the Study:

  • To investigate the role and regulation of MNKs in HER2-overexpressing breast cancer cell lines.
  • To characterize MNK activation status and its correlation with HER2 overexpression.

Main Methods:

  • Utilized a panel of breast cell lines, including HER2-overexpressing lines.
  • Generated a phosphospecific antibody to detect T-loop phosphorylation of MNKs.
  • Assessed MNK, ERK, and RSK activation and phosphorylation levels.

Main Results:

  • Phosphorylation at Thr-209 and Thr-214 in MNK1 is essential for its activation.
  • Increased MNK phosphorylation and activity were observed in HER2-overexpressing cells.
  • MNK inhibition significantly reduced colony formation in soft agar assays.

Conclusions:

  • MNK activation correlates with HER2 overexpression in breast cancer cells.
  • MNKs represent potential therapeutic targets for HER2-overexpressing breast cancers.
  • Targeting MNKs may offer a novel treatment strategy for specific breast cancer subtypes.

More Related Videos

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells16:24

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells

Published on: February 21, 2014

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...